A national study on prescribed medicine use in Australia on a typical day.

Claire E Wylie Benjamin Daniels Jonathan Brett Sallie-Anne Pearson Nicholas Alan Buckley

Published in: Pharmacoepidemiology and drug safety (2020)

Rates of polypharmacy were high, particularly in the people most susceptible to polypharmacy-related harm. Strategies to optimise the risk-benefit ratio of medicines and to reduce polypharmacy through "choosing wisely" and "de-prescribing" in this age group are needed. Australia's national data provides a benchmark to inform global medicine utilisation practices.

Keyphrases

adverse drug
primary care
quality improvement
healthcare
electronic health record
big data
emergency department
machine learning